Kolkata’s Medica Superspecialty Hospital (MSH) in collaboration with Kings College, London, and UK-based Britannia Pharmaceuticals, has launched 'Apomorphine Pen and Pump’ that treat Parkinson’s disease.
Dr Sunandan Basu, Consultant Neurosurgeon, MSH, said that Apomorphine is a highly selective dopamine receptor emulator, which promotes the release of dopamine in the brain from the nerve cells.
Dr. Vinod Metta, Consultant Interventional Neurologist, Kings College Hospital, London, and Medical Advisor to Britannia Pharmaceuticals India, said that Apomorphine pens work dramatically on patients within a couple of minutes and are very similar in usage to Insulin Pens.
Prof. Kallol Ray Chaudhuri, Director of National Parkinson’s Foundation Center, King’s College, the United Kingdom, feels that “It was indeed long overdue for Indian patients. These therapies will add significantly to the benefit of patient care and reduce caregiver burden.”
Constantino Savinnidis, International Lead & Business Director, Britannia Pharmaceuticals, UK, concluded: “It is a great honour for us to deliver Apomorphine pump and pen through Medica Hospitals for deserving patients in the entire eastern region.”